Rapid detection of specific messenger RNAs in thyroid carcinomas by reverse transcription-PCR with degenerate primers: Specific expression of oncofetal fibronectin messenger RNA in papillary carcinoma

Cancer Research

Volumn 57, Issue 17, 1997, Pages 3792-3797

  Takano, Toru ^a   Matsuzuka, Fumio ^b   Sumizaki, Hiromi ^a   Kuma, Kanji ^b   Amino, Nobuyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b KUMA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; MESSENGER RNA;

ANAPLASTIC CARCINOMA; ARTICLE; CANCER DIAGNOSIS; ELECTROPHORESIS; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; NORTHERN BLOTTING; PAPILLARY CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SEQUENCE ANALYSIS; THYROID CARCINOMA;

ADENOMA; BASE SEQUENCE; BLOTTING, NORTHERN; CARCINOMA, PAPILLARY; DNA PRIMERS; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; THYROID GLAND; THYROID NEOPLASMS;

EID: 0030846222     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Hart, I. R., and Vile, R. G. Targeted gene therapy. Br. Med. Bull., 51: 647-655, 1995.
2. Zwiebel, J. A., Su, N., MacPherson, A., Davis, T., and Ojeifo, J. O. The gene therapy of cancer: transgenic immunotherapy. Semin. Hematol., 30(Suppl. 4): 119-129, 1993.
3. Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, H. A., and Arnheim, N. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science (Washington DC), 230: 1350-1354, 1985.
4. Veres, G., Gibbs, R. A., Scherer, S. E., and Caskey, C. T. The molecular basis of the sparse fur mouse mutation. Science (Washington DC), 237: 415-417, 1987.
5. Hedinger, C. Williams, E. D., and Sobin, L. H. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer (Phila.), 63: 908-911, 1989.
6. Hamburger, J. I. Diagnosis of thyroid nodules by fine needle biopsy: use and abuse. J. Clin. Endocrinol. & Metab., 79: 335-339, 1994.
7. Sciacchitano, S., Paliotta, D. S., Nardi, F., Sacchi, A., Andreoli, M., and Pontecorvi, A. PCR amplification and analysis of ras oncogenes from thyroid cytologic smears. Diagn. Mol. Pathol., 3: 114-121, 1994.
8. Weiss, M., Baruch, A., Keydar, I., and Wreschner, D. H. Preoperative diagnosis of thyroid papillary carcinoma by reverse transcriptase polymerase chain reaction of the MUC1 gene. Int. J. Cancer, 66: 55-59, 1996.
9. Di-Carlo, A., Mariano, A., Pisano, G., Parmeggiani, U., Beguinot, L., and Macchia, V. Epidermal growth factor receptor and thyrotropin response in human thyroid tissues. J. Endocrinol. Invest., 13: 293-299, 1990.
10. Aasland, R., Lillehaug, J. R., Male, R., Josendal, O., Varhaug, J. E., and Kleppe, K. Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB. Br. J. Cancer, 57: 358-363, 1988.
11. Minuto, F., Barreca, A., Del-Monte, P., Cariola, G., Torre, G. C., and Giordano, G. Immunoreactive insulin-like growth factor I (IGF-I) and IGF-I-binding protein content in human thyroid tissue. J. Clin. Endocrinol. Metab., 68: 621-626, 1989.
12. Dobashi, Y., Sakamoto, A., Sugimura, H., Mernyei, M., Mori, M., Oyama, T., and Machinami, R. Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma. Am. J. Surg. Pathol., 17: 375-381, 1993.
13. Kotani, T., Aratake, Y., Ogata, Y., Umeki, K., Araki, A., Hirai, K., Kuma, K., and Ohtaki, S. Expression of dipeptidyl aminopeptidase IV activity in thyroid carcinoma. Cancer Lett., 57: 203-208, 1991.
14. Takano, T., Sumizaki, H., Nakano, N., Matsuzuka, F., Kuma, K., and Amino, N. Increased expression of CD44 variants in differentiated thyroid cancers. Jpn. J. Cancer Res., 87: 1245-1250, 1996.
15. Liang, P., and Pardee, A. B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science (Washington DC), 257: 967-971, 1992.
16. Sun, Y., Hegamyer, G., and Colburn, N. H. Molecular cloning of five messenger RNAs differentially expressed in preneoplastic or neoplastic JB6 mouse epidermal cells: one is homologous to human tissue inhibitor of metalloproteinases-3. Cancer Res., 54: 1139-1144, 1994.
17. Taylor, G. R., and Logan, W. P. The polymerase chain reaction: new variations on an old theme. Curr. Opin. Biotechnol., 6: 24-29, 1995.
18. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
19. Xu, Y. H., Ishii, S., Clark, A. J., Sullivan, M., Wilson, R. K., Ma, D. P., Roe, B. A., Merlino, G. T., and Pastan. I. Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells. Nature (Lond.), 309: 806-810, 1984.
20. Kornblihtt, A. R., Umezawa, K., Vibe-Pedersen, K., and Baralle, F. E. Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. EMBO J., 4: 1755-1759, 1985.
21. Ohagi, S., LaMendola, J., LeBeau, M. M., Espinosa III, R., Takeda, J., Smeekens, S. P., Chan, S. J., and Steiner, D. F. Identification and analysis of the gene encoding human PC2, a prohormone convertase expressed in neuroendocrine tissues. Proc. Natl. Acad. Sci. USA, 89: 4977-4981, 1992.
22. Musti, A. M., Avvedimento, E. V., Polistina, C., Ursini, V. M., Obici, S., Nitsch, L., Cocozza, S., and DiLauro, R. The complete structure of the rat thyroglobulin gene. Proc. Natl. Acad. Sci. USA, 83: 323-327, 1989.
23. Dveksler, G. S., Basile, A. A., and Dieffenback, C. W. Analysis of gene expression: use of oligonucleotide primers for glyceraldehyde-3-phosphate dehydrogenase. PCR Methods Appl., 1: 283-285, 1992.
24. Pelizzo, M. R., Piotto, A., Rubello, D., Casara, D., Fassina, A., and Busnardo, B. High prevalence of occult papillary thyroid carcinoma in a surgical series for benign thyroid disease. Tumori, 76: 255-257, 1990.
25. Yamada, K. M., and Weston, J. A. Isolation of a major cell surface glycoprotein from fibroblasts. Proc. Natl. Acad. Sci. USA, 71: 3492-3496, 1974.
26. Matsuura, H., and Hakomori, S. The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma. Proc. Natl. Acad. Sci. USA, 82: 6517-6521, 1985.
27. Mandel, U., Gaggero, B., Reibel, J., Therkildsen, M. H., Dabelsteen, E., and Clausen, H. Oncofetal fibronectins in oral carcinomas: correlation of two different types. APMIS, 102: 695-702, 1994.
28. Loridon-Rosa, B., Vielh, P., Matsuura, H., Clausen, H., Cuadrado, C., and Burtin, P. Distribution of oncofetal fibronectin in human mammary tumors: immunofluorescence study on histological sections. Cancer Res., 50: 1608-1612, 1990.
29. Inufusa, H., Nakamura, M., Adachi, T., Nakatani, Y., Shindo, K., Yasutomi, M., and Matsuura, H. Localization of oncofetal and normal fibronectin in colorectal cancer: correlation with histologic grade, liver metastasis. Cancer (Phila.), 75: 2802-2808, 1995.
30. David, L., Mandel, U., Clausen, H., and Sobrinho-Simoes, M. Immunohistochemical expression of oncofetal fibronectin in benign and malignant lesions of the stomach. Eur. J. Cancer, 29A: 2070-2071, 1993.
31. 131I uptakes after triiodothyronine withdrawal in patients with thyroid cancer. J. Clin. Endocrinol. Metab., 53: 1199-1206, 1981.
32. Kaczmarek, J., Castellani, P., Nicolo, G,. Spina, B., Allemanni, G., and Zardi, L. Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int. J. Cancer, 59: 11-16, 1994.
33. Scopsi, L., Gullo, M. Rilke, F., Martin, S., and Steiner, D. F. Proprotein convertases (PC1/PC3 and PC2) in normal and neoplastic human tissues: their use as markers of neuroendocrine differentiation. J. Clin. Endocrinol. Metab., 80: 294-301, 1995.